| SpectraBase Spectrum ID |
JH5mqcVEGKe |
| Name |
Flibanserin |
| CAS Registry Number |
167933-07-5 |
| Classification |
Pharmaceutical drug, hypoactive sexual desire disorder (HSDD) |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
390.166745800 u |
| Formula |
C20H21F3N4O |
| InChI |
InChI=1S/C20H21F3N4O/c21-20(22,23)15-4-3-5-16(14-15)26-11-8-25(9-12-26)10-13-27-18-7-2-1-6-17(18)24-19(27)28/h1-7,14H,8-13H2,(H,24,28) |
| InChIKey |
PPRRDFIXUUSXRA-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
390.410 g/mol |
| Nominal Mass |
390 u |
| Quality |
998 |
| Retention Index |
3096 |
| SMILES |
C12=C(NC(N2CCN2CCN(C=3C=C(C(F)(F)F)C=CC3)CC2)=O)C=CC=C1 |
| SPLASH |
splash10-0fdo-4590000000-2ec7a8d228bfee39f489 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Addyi
BIMT-17
1-(2-(4-[3-(Trifluoromethyl)phenyl]piperazin-1-yl)ethyl)-1,3-dihydro-2H-benzimidazol-2-one |
| Technique |
GC/MS |
| Wiley ID |
DD2024_019010 |
